Boston Scientific
863 hedge funds and large institutions have $46.2B invested in Boston Scientific in 2020 Q4 according to their latest regulatory filings, with 127 funds opening new positions, 336 increasing their positions, 289 reducing their positions, and 99 closing their positions.
28% more first-time investments, than exits
New positions opened: 127 | Existing positions closed: 99
16% more repeat investments, than reductions
Existing positions increased: 336 | Existing positions reduced: 289
7% more funds holding in top 10
Funds holding in top 10: 14 → 15 (+1)
2% more funds holding
Funds holding: 843 → 863 (+20)
2.76% less ownership
Funds ownership: 91.63% → 88.87% (-2.8%)
8% less capital invested
Capital invested by funds: $50B → $46.2B (-$3.85B)
26% less call options, than puts
Call options by funds: $248M | Put options by funds: $335M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$673M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$402M |
| 3 |
D.E. Shaw & Co
New York
|
+$337M |
| 4 |
Two Sigma Investments
New York
|
+$228M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$206M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$1.94B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.01B |
| 3 |
SCM
Steadfast Capital Management
New York
|
-$362M |
| 4 |
FAM
Fred Alger Management
New York
|
-$341M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$331M |
BSX Hedge Fund Activity: Q4 2020 in Review
863 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2020, worth a combined $46.2B — down 7.7% from $50B a quarter earlier.
Buyers outnumbered sellers: 127 funds opened new BSX positions and 99 closed out — a net gain of 28 holders — while 336 added to existing stakes and 289 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $673M. The largest seller was Capital World Investors, cutting an estimated $1.94B.
- 863 institutional investors held Boston Scientific (BSX) as of Q4 2020, up from 843 in Q3 2020.
- Funds reported $46.2B of Boston Scientific stock for Q4 2020, down 7.7% quarter-over-quarter.
- 127 funds opened new Boston Scientific positions in Q4 2020 and 99 closed out, a net change of +28 holders.
- The largest Boston Scientific buyer in Q4 2020 was Wellington Management Group, an estimated $673M added.
- The largest Boston Scientific seller in Q4 2020 was Capital World Investors, an estimated $1.94B sold.
Based on aggregated 13F filings for Q4 2020.